4
Changes in Ownership
SUTRO BIOPHARMA, INC. Filed Acc 0001415889-25-010383
Options or other derivatives
- Chief Business Dev. Officer acquired 175,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Leyman Barbara Chief Business Dev. Officer | 2025-04-04 | Grant or award · Stock Option (Right to Buy) | +91,000 | 91,000 | D | ||
| Leyman Barbara Chief Business Dev. Officer | 2025-04-04 | Grant or award · Restricted Stock Units (RSUs) | +84,500 | 84,500 | D | ||
Loading xslF345X05/form4-04082025_080432.xml…